Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Hematology | Family Medicine
Search Medical Condition
Anemia Clinical Trials
A listing of Anemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (508) clinical trials
COMMANDS - Myelodysplastic Syndromes (MDS) - ACE536-MDS-002 - US
Anemia is considered to be one of the most prevalent cytopenias in patients who have myelodysplastic syndromes, an umbrella term used to describe disorders relating to the ineffective production of red blood cells, white blood cells, and/or platelets. Ranging in severity from mild (asymptomatic) to severe, anemia can result in ...
Iron Deficiency Anemia
Fever? Aches? Pains? Cough? Sore Throat? When you reach for the tissues this flu season, think Global Medical Research. Global Medical Research is enrolling in a study that will try to find out if an investigational flu drug can speed up the recovery of people with flu.
Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).
A Multicenter, Randomized, Open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD Qualified Participants will receive at no cost to them. Study Medication Study Related Labs Physical Exams Rescue Medication Compensation for your time and travel for each completed study visit To Lean More ...
Iron Deficiency anemia
Iron deficiency anemia (IDA) is most common in patients with cancer, chronic kidney disease, and gastrointestinal diseases such as inflammatory bowel diseases, menstruating or pregnant women, and patients who have undergone gastric bypass surgeries. IDS can have a significant impact on a person's quality of life, so it is important ...
Anemia Clinical Trial
We are testing new investigational medications for anemia. We are currently seeking women and men to participate in a clinical research study.
A Phase III, Randomised, Open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer®) and iron sucrose in subjects with iron deficiency anemia who are intolerant or unresponsive to oral iron therapy.
The trial is a randomised, comparative, open-label trial. Subjects with iron deficiency anemia (IDA) who are intolerant or unresponsive to oral iron therapy or in whom the screening haemoglobin (Hb) measurement in Investigators' opinion were sufficiently low as to require rapid repletion of iron stores to minimize the risk of ...
AKB-6548-CI-0014 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE MAINTENANCE TREATMENT OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT- CONVERSION
ANEMIA RELATED TO CHRONIC KIDNEY DISEASE. NAIVE OR CURRENTLY RECEVING ESA
AKB-6548-CI-0014 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION) AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE MAINTENANCE TREATMENT OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT- CONVERSION
ANEMIA RELATED TO CHRONIC KIDNEY DISEASE. NAIVE OR CURRENTLY RECEVING ESA
Phase 3, randomized, open-label, active-controlled study evaluating the efficacy and safety of oral vadadustat for the correction of anemia in subjects with non-dialysis-dependent chronic kidney disease (ndd-ckd) (pro2tect - correction)
The study drug (vadadustat) is an investigational drug. This potential new drug is being tested to treat anemia (low red blood cell count) in patients with chronic (long-term) kidney disease. This is a Phase 3 study, which means that the study drug has already been tested in other studies involving ...
